Advertisement Onconova adopts BioClinica Express - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Onconova adopts BioClinica Express

Onconova Therapeutics has extended its agreement with BioClinica to make use of its BioClinica Express electronic data capture (EDC) and data management services which would help support clinical trials.

BioClinica Express EDC offers standard RECIST (Response Evaluation Criteria In Solid Tumors) eCRFs that automatically calculate overall tumor response based on the data entered.

A dynamic lesion form uses derived data to help sites consistently track lesions from visit to visit.

Onconova has adopted many eCRFs (electronic case report forms) and tools developed by BioClinica specifically to support oncology trials.

BioClinica has also helped Onconova in developing a custom study drug re-supply algorithm to support its study design, implemented a daily lab import feed to minimize data entry and a local lab range import to streamline reconciliation.